z-logo
open-access-imgOpen Access
Synthesis, characterization, quantum chemical calculations and anticancer activity of a Schiff base NNOO chelate ligand and Pd(II) complex
Author(s) -
Shahrul Nizam Ahmad,
El Hassane Anouar,
Amalina Mohd Tajuddin,
Kalavathy Ramasamy,
Bohari Mohd. Yamin,
Hadariah Bahron
Publication year - 2020
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0231147
Subject(s) - bathochromic shift , density functional theory , schiff base , chemistry , ligand (biochemistry) , crystallography , absorption spectroscopy , basis set , chemical shift , quantum chemical , proton nmr , infrared spectroscopy , molecule , computational chemistry , stereochemistry , organic chemistry , physics , biochemistry , receptor , quantum mechanics , fluorescence
This paper reports the synthesis, characterization, anticancer screening and quantum chemical calculation of a tetradentate Schiff base 2,2'-((1 E ,1' E )-((2,2-dimethylpropane-1,3-diyl)bis- (azanylylidene))bis(methanylylidene))bis(4-fluorophenol) ( L2F ) and its Pd (II) complex ( PdL2F ). The compounds were characterized via UV-Visible, NMR, IR spectroscopy and single crystal x-ray diffraction. Density Functional Theory (DFT) and time-dependent DFT calculations in gas and solvent phases were carried out using B3LYP, B3P86, CAM-B3LYP and PBE0 hybrid functionals combined with LanL2DZ basis set. Complexation of L2F to form PdL2F was observed to cause a bathochromic shift of the maximum absorption bands of n–π* from 327 to 410 nm; an upfield shift for δ (HC = N) from 8.30 to 7.96 ppm and a decreased wavenumber for ν(C = N) from 1637 to 1616 cm -1 . Overall, the UV-Vis, NMR and IR spectral data are relatively well reproduced through DFT and TD-DFT methods. L2F and PdL2F showed IC 50 of 90.00 and 4.10 μg/mL, respectively, against human colorectal carcinoma (HCT116) cell lines, signifying increased anticancer activity upon complexation with Pd (II).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here